SNOA News and Press, Sonoma Pharmaceuticals Inc. From 03/12/19

PETALUMA, Calif., March 12, 2019 (GLOBE NEWSWIRE) -- Specialty pharmaceutical company Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), today announced substantial cost-cutting measures, including reductions to the company’s workforce and management.    The measures come on t...

PETALUMA, Calif., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA) today announced that financial results for its fiscal year 2019 second quarter, ended September 30, 2018, will be released after the U.S. markets close on November 8, 2018.  The earnings rel...

PETALUMA, Calif., Oct. 25, 2018 (GLOBE NEWSWIRE) -- Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), today announced newly published results from a study into the use of the company’s proprietary Performance Stabilized HOCl TM (hypochlorous acid) for the management of scars. The newly p...

PETALUMA, Calif., Sept. 19, 2018 (GLOBE NEWSWIRE) -- Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), today announced the appointment of Philippe Weigerstorfer to the company’s board of directors.  Weigerstorfer brings extensive pharmaceutical and dermatology experience to Sonoma...

Results from study evaluating Sonoma Pharmaceuticals' (NASDAQ: SNOA ) topical high-strength Performance-Stabilized HOCI in patients with mild-to-moderate acne vulgaris showed a treatment effect. The data were presented at the Practical Symposium Dermatology Conference in Colorado. More ...

PETALUMA, Calif., Aug. 28, 2018 (GLOBE NEWSWIRE) -- Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), today announced that results from a study into the use of the company’s proprietary high-strength Performance-Stabilized HOCl TM in the management of acne vulgaris were presented at the ...

Gainers: TMSR +50% . AWX +48% . MDLY +45% . TTD +35% . CORI +22% . SNOA +21% . OSTK +19% . PVG +18% . CKPT +18% . TRUE +17% . More news on: TMSR Holding Co., Ltd., Avalon Holdings Corporation, Medley Management, Stocks on the move, , Read more ...

Thinly traded nano cap Sonoma Pharmaceuticals ( SNOA +20.1% ) is up on more than double normal volume, albeit on turnover of only 177K shares, as it tries to break free of a long-term downtrend that began in Q1 2017. More news on: Sonoma Pharmaceuticals, Inc., Healthcare stocks news, Sto...